Achillion Pharmaceuticals is based out of Frederick. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. It focuses on the development of antivirals for the treatment of HIV infection and chronic hepatitis C; and antibacterials for the treatment of serious hospital-based bacterial infections. The company's lead drug candidate is elvucitabine, an antiviral in phase II clinical trials for the treatment of HIV infection. It also develops ACH-702, a preclinical candidate for the treatment of serious hospital-based bacterial infection; and NS4A Antagonists, a preclinical-stage program for chronic hepatitis C. The company has research collaboration with Gilead Sciences, Inc. to develop and commercialize compounds for the treatment of chronic hepatitis C.Whalewisdom has at least 218 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2010-08-23. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
ACHILLION PHARMACEUTICALS INC1003 WEST SEVENTH ST
FREDERICK MD 21701
Business Phone: 3016968889
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS